The 2013 Australian Museum Eureka Prizes were last week awarded across 17 fields, recognising achievements in research and innovation; leadership and commercialisation; science communication and journalism; and school science. [ + ]

The drive for the early diagnosis of dementia may be resulting in overdiagnosis and inappropriate treatment. [ + ]

Nominations will close shortly for candidates to nominate for the AusBiotech board of directors and for the Janssen 2013 Industry Excellence Awards, which recognise those who have made a significant contribution to the biotechnology industry. [ + ]

A newly discovered protein in the venom of Australian tarantulas shows promise as a bioinsecticide for cotton crop pests. [ + ]

Researchers at Curtin University, in collaboration with The University of Western Australia (UWA), will soon be developing a new whooping cough vaccine. [ + ]

Bioniche (ASX:BNC) will replace its current CEO and change the make-up of its board, after settling a dispute with dissident shareholders over the planned sale of its animal health businesses. [ + ]

The UK's MHRA has given its final approval for a phase I/II study of Viralytics' oncolytic virus in melanoma, prostate, lung or metastatic bladder cancers. [ + ]

DNA barcoding is facilitating the identification of rainforest plant species in Queensland. [ + ]

Australia-based CRO SYNthesis med chem has opened a UK facility to support its existing labs in Melbourne and Shanghai. [ + ]

Scientists from Flinders University are collaborating with clinicians from Flinders Medical Centre to make a class of cancer drugs more effective by allowing patients to receive the dose that is best for them. [ + ]

TTS Australia 2013 brought together 150 leading tech transfer professionals from Australia and the international community to help build expertise and relationships that enable successful tech transfer - that which results in the translation of research into products to benefit our community. [ + ]

InventorOne-The Andrew Abolafia Co has discovered that there are large amounts of intrinsic energy stored in certain types of permanent magnets. The company has now invented a device to extract that energy and convert it to electric power in a practical and cost-effective manner. [ + ]

QRxPharma (ASX:QRX) will meet with the US FDA in October to discuss the issues raised in the latest Complete Response Letter for dual-opioid drug MoxDuo. [ + ]

pSivida (ASX:PVA) will this week make presentations at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference. [ + ]

iSonea (ASX:ISN) has gained the certification required for a CE Mark for its AirSonea wheeze monitoring tool, paving the way for an EU launch following its debuts in Australia and the US. [ + ]